Medicare Enrolled
Dr. Rambabu Tummala, MD
Medical Oncology · Leesburg, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tummala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tummala?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tummala
Dr. Rambabu Tummala is a medical oncology specialist in Leesburg, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tummala performed 115,068 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Tummala received a total of $9,912 from 78 pharmaceutical and/or device companies across 489 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tummala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 22% volume in FL
$9,912 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗115,068
Medicare services
Top 22% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
37,740 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 23,400 | $43 | $137 |
| Denosumab injection (Prolia/Xgeva) | 14,580 | $18 | $51 |
| Anti-nausea injection (aprepitant) | 10,790 | $1 | $5 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
10,060 | $6 | $23 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,044 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,938 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,881 | $8 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,773 | $64 | $239 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,180 | $1 | $28 |
| Anti-nausea injection (ondansetron/Zofran) | 1,145 | $0 | $9 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
876 | $10 | $69 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
643 | $11 | $61 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
545 | $97 | $339 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
532 | $95 | $378 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
339 | $1 | $6 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
207 | $1 | $3 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
169 | $47 | $189 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
152 | $7 | $69 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
133 | $124 | $453 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
132 | $4 | $10 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
131 | $21 | $79 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
122 | $28 | $156 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
120 | $17 | $59 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
114 | $48 | $178 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
85 | $22 | $84 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
43 | $103 | $377 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
42 | $2 | $8 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
37 | $2 | $7 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
36 | $10 | $42 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
36 | $16 | $56 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
23 | $3 | $11 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
20 | $25 | $156 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
33.7% high complexity
58.8% medium
7.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,912
Total received (2018-2024)
Avg $1,416/year across 7 years
Top 43% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
78
Companies
489
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,144
2023
$1,841
2022
$1,742
2021
$1,299
2020
$631
2019
$1,025
2018
$1,230
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$218
Celgene Corporation
$203
Incyte Corporation
$138
Merck Sharp & Dohme LLC
$138
SOBI, INC
$105
GENZYME CORPORATION
$99
Regeneron Healthcare Solutions, Inc.
$90
Lilly USA, LLC
$88
AstraZeneca Pharmaceuticals LP
$85
Gilead Sciences, Inc.
$84
Daiichi Sankyo Inc.
$68
PFIZER INC.
$67
Eisai Inc.
$67
Takeda Pharmaceuticals U.S.A., Inc.
$63
E.R. Squibb & Sons, L.L.C.
$57
Janssen Biotech, Inc.
$57
ABBVIE INC.
$46
Pharmacosmos Therapeutics Inc.
$41
BeiGene USA, Inc.
$38
Astellas Pharma US Inc
$33
ARRAY BIOPHARMA INC
$30
PharmaEssentia USA Corporation
$30
TerSera Therapeutics LLC
$29
Tolmar, Inc.
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$26
GlaxoSmithKline, LLC.
$26
Kite Pharma, Inc.
$25
Tempus AI, Inc
$23
Alexion Pharmaceuticals, Inc.
$23
ADC Therapeutics America, Inc.
$23
SERVIER PHARMACEUTICALS LLC
$22
Adaptive Biotechnologies Corporation
$21
Stemline Therapeutics Inc.
$20
PUMA BIOTECHNOLOGY, INC.
$18
Bayer Healthcare Pharmaceuticals Inc.
$14
Top 3 companies account for 26.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$920
Janssen Biotech, Inc.
$818
E.R. Squibb & Sons, L.L.C.
$674
Incyte Corporation
$477
Merck Sharp & Dohme LLC
$387
GENZYME CORPORATION
$380
Takeda Pharmaceuticals U.S.A., Inc.
$373
Amgen Inc.
$330
Celgene Corporation
$316
Seagen Inc.
$290
Lilly USA, LLC
$280
Genentech USA, Inc.
$277
AstraZeneca Pharmaceuticals LP
$231
PFIZER INC.
$220
Astellas Pharma US Inc
$213
Eisai Inc.
$212
Merck Sharp & Dohme Corporation
$179
Regeneron Healthcare Solutions, Inc.
$170
Daiichi Sankyo Inc.
$160
Gilead Sciences, Inc.
$159
Foundation Medicine, Inc.
$142
EMD Serono, Inc.
$138
Bayer HealthCare Pharmaceuticals Inc.
$132
SOBI, INC
$126
Pharmacyclics LLC, an AbbVie Company
$122
TerSera Therapeutics LLC
$111
Kite Pharma, Inc.
$103
ARRAY BIOPHARMA INC
$100
Alexion Pharmaceuticals, Inc.
$94
Pharmacyclics LLC, An AbbVie Company
$91
Myriad Genetic Laboratories, Inc.
$78
GlaxoSmithKline, LLC.
$76
BeiGene USA, Inc.
$73
Stemline Therapeutics Inc.
$68
Boehringer Ingelheim Pharmaceuticals, Inc.
$66
ABBVIE INC.
$64
Pharmacosmos Therapeutics Inc.
$64
Bayer Healthcare Pharmaceuticals Inc.
$63
AMAG Pharmaceuticals, Inc.
$59
PharmaEssentia USA Corporation
$54
G1 Therapeutics, Inc.
$53
Spectrum Pharmaceuticals Inc.
$50
TESARO, Inc.
$50
ADC Therapeutics America, Inc.
$44
MorphoSys, US Inc.
$40
Dova Pharmaceuticals
$40
Ipsen Biopharmaceuticals, Inc
$40
PUMA BIOTECHNOLOGY, INC.
$39
EISAI INC.
$39
TG THERAPEUTICS, INC.
$33
Sun Pharmaceutical Industries Inc.
$33
Agios Pharmaceuticals, Inc.
$32
Janssen Pharmaceuticals, Inc
$32
Genmab U.S., Inc.
$29
Puma Biotechnology, Inc.
$27
Tolmar, Inc.
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$26
Innate Pharma, Inc
$24
Tempus AI, Inc
$23
JAZZ PHARMACEUTICALS INC.
$23
SERVIER PHARMACEUTICALS LLC
$22
Array BioPharma Inc.
$21
RECORDATI_RARE_DISEASES_INC.
$21
Adaptive Biotechnologies Corporation
$21
Epizyme, Inc.,
$20
Apellis Pharmaceuticals, Inc.
$20
Taiho Oncology, Inc.
$20
Seattle Genetics, Inc.
$19
Rigel Pharmaceuticals, Inc.
$18
Mirati Therapeutics, Inc.
$18
Heron Therapeutics, Inc.
$17
GE HealthCare
$16
Kyowa Kirin, Inc.
$16
CTI BioPharma Corp.
$15
Karyopharm Therapeutics Inc.
$15
Global Blood Therapeutics, Inc.
$14
Sobi, Inc
$14
Clovis Oncology, Inc.
$14
Top 3 companies account for 24.3% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AUGTYRO · Alecensa · Aliqopa · Avastin · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRACAnalysis CDx · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CALQUENCE · CEREZYME · COSELA · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELZONRIS · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · Erleada · FARESTON · FERAHEME · FOUNDATIONONE · FRUZAQLA · Folotyn · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lumoxiti · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Odomzo · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Perjeta · Polivy · Prolia · Quzyttir · REBLOZYL · ROLVEDON · RYDAPT · Revlimid · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SYLVANT · SYNAGIS · Somatuline Depot · Stivarga · TASIGNA · TAZVERIK · TECENTRIQ · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Trodelvy · UKONIQ · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Vanflyta · Vitrakvi · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
7
County median income
$69,956
Nearest hospital to ZIP centroid (approximate)
VILLAGES REGIONAL HOSPITAL, THE
7.0 mi
7.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tummala is a mixed practice specialist, with above-average Medicare volume (top 22% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tummala experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Tummala performed 37,740 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Tummala receive payments from pharmaceutical companies?
Yes. Dr. Tummala received a total of $9,912 from 78 companies across 489 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tummala's costs compare to other medical oncologists in Leesburg?
Dr. Tummala's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tummala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Leesburg
Browse medical oncologists in Leesburg ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology